A377220 Stock Overview
Manufactures and sells health related products in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
From Bio Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩2,130.00 |
52 Week High | ₩3,580.00 |
52 Week Low | ₩1,454.00 |
Beta | 0.22 |
11 Month Change | -9.94% |
3 Month Change | 29.96% |
1 Year Change | -36.70% |
33 Year Change | -65.78% |
5 Year Change | n/a |
Change since IPO | -78.54% |
Recent News & Updates
Shareholder Returns
A377220 | KR Food | KR Market | |
---|---|---|---|
7D | -2.3% | 1.2% | -1.2% |
1Y | -36.7% | 4.2% | 4.8% |
Return vs Industry: A377220 underperformed the KR Food industry which returned 4.2% over the past year.
Return vs Market: A377220 underperformed the KR Market which returned 4.8% over the past year.
Price Volatility
A377220 volatility | |
---|---|
A377220 Average Weekly Movement | 8.1% |
Food Industry Average Movement | 4.8% |
Market Average Movement | 6.7% |
10% most volatile stocks in KR Market | 12.2% |
10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A377220 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A377220's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 128 | n/a | www.frombio-company.co.kr |
From Bio Co.,Ltd manufactures and sells health related products in South Korea. The company offers health functional food, health beauty, living health, and cosmetic products. It operates an online platform to retail its products.
From Bio Co.,Ltd Fundamentals Summary
A377220 fundamental statistics | |
---|---|
Market cap | ₩60.30b |
Earnings (TTM) | -₩16.64b |
Revenue (TTM) | ₩67.29b |
0.9x
P/S Ratio-3.6x
P/E RatioIs A377220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A377220 income statement (TTM) | |
---|---|
Revenue | ₩67.29b |
Cost of Revenue | ₩21.91b |
Gross Profit | ₩45.38b |
Other Expenses | ₩62.02b |
Earnings | -₩16.64b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -587.95 |
Gross Margin | 67.44% |
Net Profit Margin | -24.74% |
Debt/Equity Ratio | 34.8% |
How did A377220 perform over the long term?
See historical performance and comparison